secwatch.observer — SEC 8-K summary
======================================

Issuer:     EXAGEN INC. (XGN)
CIK:        0001274737
Form:       8-K
Filed at:   2024-01-08T23:59:59+00:00
Accession:  0001274737-24-000006
Event type: earnings
Sentiment:  neutral
Materiality: 0.55
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Exagen reports record AVISE CTD volume of ~137k units, reaffirms FY2023 guidance
--------------------------------------------------------------------------------

- Record AVISE® CTD testing volume of approx. 137,000 units in FY2023.
- Cash balance of $36.5M as of Dec 31, 2023; AR approx. $7M.
- Reaffirms FY2023 revenue guidance of at least $50M, non-GAAP adjusted EBITDA of approx. -$20M.
- Management points to streamlined operations and revamped expense structure toward profitability.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1274737/000127473724000006/0001274737-24-000006-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1274737/000127473724000006/exdx-20240107.htm
  HTML page:      https://secwatch.observer/filing/0001274737-24-000006

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer